Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

33.93
Delayed Data
As of 4:02pm ET
 +0.38 / +1.13%
Today’s Change
30.89
Today|||52-Week Range
59.00
-41.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
AssetsCash2.5B736.9M2.0B2.2B
 
 
 
 
 
Short Term Investment Cash146.2M-1.7B1.2B196.7M
 
 
 
 
 
Cash & Short Term Investments3.0B1.6B2.4B2.6B
 
 
 
 
 
 
ReceivablesReceivables3.0B3.1B3.1B2.6B
 
 
 
 
 
 
InventoriesInventories1.9B2.0B2.0B2.2B
 
 
 
 
 
 
Current AssetsPrepaid Expenses127.9M------
 
 
Other Current Assets0.00401.8M409.2M412.6M
 
 
 
 
Current Assets8.0B7.1B7.9B7.8B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross7.4B------
 
 
Depreciation-3.7B------
 
 
Intangible Assets314.1M329.9M314.9M430.0M
 
 
 
 
 
Other Assets314.1M329.9M314.9M430.0M
 
 
 
 
 
Total Assets13.4B12.6B13.2B13.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable717.2M572.0M796.4M673.4M
 
 
 
 
 
Short Term Debt156.2M62.1M60.6M68.8M
 
 
 
 
 
Accrued Expenses850.1M------
 
 
Other Current Liabilities3.9B4.9B4.7B4.7B
 
 
 
 
 
Other Liabilities5.9B6.3B6.2B6.3B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-989.8M-917.1M-664.4M-404.6M
 
 
 
 
 
Other Liabilities0.000.000.000.00
 
 
 
Total Liabilities6.5B6.9B6.8B6.9B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity6.8B5.7B6.4B6.2B
 
 
 
 
 
Total Shareholder Equity6.8B5.7B6.4B6.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0B2.1B2.0B2.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.